Literature DB >> 18242135

Case report and review: epicardial coronary artery fibromuscular dysplasia.

Anthony Camuglia1, Vance Manins, Andrew Taylor, Chris Hengel.   

Abstract

Fibromuscular dysplasia (FMD) of the epicardial coronary arteries is an uncommon entity. We describe the first published case of this condition presenting as a transient ischaemic attack due to thromboembolism from intracardiac thrombus secondary to silent myocardial infarction. We also present the first published case of epicardial coronary FMD with sparing of the renal arteries. This case provides further evidence that FMD of the epicardial coronary arteries frequently involves the mid to distal segments of the left anterior descending artery. A brief review of the literature on FMD is presented.

Entities:  

Mesh:

Year:  2008        PMID: 18242135     DOI: 10.1016/j.hlc.2007.10.012

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  4 in total

1.  European Society of Cardiology, acute cardiovascular care association, SCAD study group: a position paper on spontaneous coronary artery dissection.

Authors:  David Adlam; Fernando Alfonso; Angela Maas; Christiaan Vrints
Journal:  Eur Heart J       Date:  2018-09-21       Impact factor: 29.983

Review 2.  Coronary artery manifestations of fibromuscular dysplasia.

Authors:  Katherine C Michelis; Jeffrey W Olin; Daniella Kadian-Dodov; Valentina d'Escamard; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2014-09-09       Impact factor: 24.094

Review 3.  Recent developments in the understanding and management of fibromuscular dysplasia.

Authors:  Sarah C O'Connor; Heather L Gornik
Journal:  J Am Heart Assoc       Date:  2014-12       Impact factor: 5.501

4.  Myocardial Infarction as the Initial Presentation for Fibromuscular Dysplasia.

Authors:  Mohammed Al-Sadawi; Ayman Battisha; Bader Madoukh; Naseem A Hossain; Khaleda Akter; Shakil Shaikh; Sayed Mahdi Ayat; Felix Nwamaghinna; Samy I McFarlane
Journal:  Am J Med Case Rep       Date:  2020-04-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.